ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2019

Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany.

Matthias Herpers et al.PubMed ↗Publisher ↗

No numbers read from the abstract.